Get Your Personalized Supplement StackSupplement Stack Quiz

Calcium L-Methylfolate

Also known as: Calcium L-methylfolate, 5-MTHF calcium salt, L-methylfolate calcium, Metafolin®, active folate, bioactive folate, L-5-methyltetrahydrofolate

Overview

Calcium L-methylfolate is the calcium salt of L-5-methyltetrahydrofolate (L-5-MTHF), which is the biologically active form of folate (vitamin B9). Unlike synthetic folic acid, L-methylfolate bypasses the enzymatic conversion steps required for the body to utilize folate, making it directly bioavailable. It is naturally present in foods like leafy greens and legumes, but its supplemental form offers higher bioavailability. Primarily, it is used to prevent or treat folate deficiency and serves as an adjunctive treatment for major depressive disorder (MDD), especially in patients who do not respond adequately to conventional antidepressants. It is also considered for supporting neural development and cardiovascular health. A key characteristic is its ability to cross the blood-brain barrier, directly participating in central nervous system folate metabolism, which is particularly beneficial for individuals with MTHFR gene polymorphisms that impair folic acid metabolism. Research on its efficacy in depression and its safety profile is well-established, supported by multiple randomized controlled trials, systematic reviews, and meta-analyses.

Benefits

Calcium L-methylfolate offers several evidence-based benefits, primarily as an adjunctive treatment for major depressive disorder (MDD). A 2021 systematic review and meta-analysis demonstrated a statistically significant improvement in depressive symptoms when L-methylfolate was used to augment antidepressant therapy, showing a favorable relative risk of response and clinically meaningful effect sizes. This benefit is particularly pronounced in patients with SSRI-resistant depression. Secondary benefits include improved folate status, especially in individuals with genetic polymorphisms (like MTHFR) that impair the metabolism of synthetic folic acid. By improving folate status, it may help reduce homocysteine levels, which could support cardiovascular and cognitive health, although these effects are less extensively studied than its role in depression. The time course for benefits typically aligns with antidepressant treatment, emerging over weeks to months of consistent use.

How it works

Calcium L-methylfolate functions as a crucial methyl donor within the one-carbon metabolism cycle, a fundamental biochemical pathway essential for DNA synthesis, repair, and various methylation processes. Its primary mechanism involves supporting the synthesis of key neurotransmitters, such as serotonin, dopamine, and norepinephrine, by providing the necessary methyl groups for their production. Unlike folic acid, L-methylfolate can directly cross the blood-brain barrier, thereby increasing folate levels within the central nervous system. This enhanced CNS folate availability is believed to improve neurotransmitter function and promote neuroplasticity, which are critical factors in the pathophysiology and treatment of depression. It also plays a vital role in the conversion of homocysteine to methionine via the enzyme methionine synthase, facilitating essential methylation reactions throughout the body. Its high bioavailability means it does not require enzymatic reduction, making it effective even in individuals with impaired folate metabolism.

Side effects

Calcium L-methylfolate is generally considered safe and well-tolerated, exhibiting a favorable safety profile in both short-term and long-term use as an adjunctive therapy. Common side effects are minimal and typically include mild gastrointestinal discomfort or headache, with their incidence being comparable to that observed with placebo. Uncommon side effects, reported in 1-5% of users, may include rare allergic reactions or mild insomnia. Serious adverse events directly attributable to calcium L-methylfolate have not been documented in high-quality clinical trials. It is generally safe to use concurrently with SSRIs and other antidepressants, as no significant drug interactions have been reported. Contraindications include known hypersensitivity to folate compounds. Caution is advised in patients with undiagnosed anemia, as folate supplementation could potentially mask a vitamin B12 deficiency. While essential in pregnancy for neural tube defect prevention, data on calcium L-methylfolate specifically in pregnant and pediatric populations are limited, though folate itself is crucial. Overall, its safety profile supports its use in adults for its indicated purposes.

Dosage

For adjunctive treatment of depression, clinical trials commonly utilize daily doses ranging from 7.5 mg to 15 mg. The most studied and effective dose for this purpose is 15 mg/day of calcium L-methylfolate. Doses up to 15 mg/day are generally well-tolerated, and higher doses are not routinely recommended due to insufficient evidence supporting increased efficacy or safety. The supplement can be taken daily, with or without food, and consistent daily intake is advised for optimal results. Calcium L-methylfolate is typically available in stable and bioavailable forms such as tablets or capsules. Its absorption is efficient and not significantly affected by food intake. It is important to ensure adequate vitamin B12 status when supplementing with L-methylfolate to prevent the masking of potential B12 deficiency symptoms, as folate can alleviate megaloblastic anemia symptoms while neurological damage from B12 deficiency progresses.

FAQs

Is Calcium L-Methylfolate Safe?

Yes, calcium L-methylfolate is generally safe and well-tolerated, with a safety profile comparable to placebo in clinical trials, especially when used as an adjunctive therapy for depression.

How Long Until Benefits Are Seen?

Improvements in depressive symptoms typically emerge within weeks of starting calcium L-methylfolate supplementation, often paralleling the response timeline observed with antidepressant medications.

Can It Replace Folic Acid?

Calcium L-methylfolate is a bioactive form of folate and may be preferred, especially for individuals with impaired folate metabolism, but folic acid remains the standard for general folate supplementation.

Are There Genetic Considerations?

Yes, individuals with MTHFR gene polymorphisms, which affect folate metabolism, may benefit more significantly from L-methylfolate supplementation compared to folic acid.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/34794190/ – This systematic review and meta-analysis evaluated the efficacy of L-methylfolate augmentation in adults with major depressive disorder. It found that L-methylfolate adjunctive therapy significantly improved depressive symptoms compared to antidepressant monotherapy, demonstrating a moderate effect size and favorable number needed to treat (NNT).
https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-1681-2047.pdf – This PDF provides detailed findings from a meta-analysis on L-methylfolate augmentation for major depressive disorder. It supports the conclusion that L-methylfolate significantly improves depressive symptoms when added to antidepressant treatment, highlighting its clinical utility.
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1681-2047 – This abstract summarizes a meta-analysis on L-methylfolate as an adjunctive treatment for MDD. It concludes that L-methylfolate significantly enhances the efficacy of antidepressants, particularly in patients who have not responded adequately to monotherapy, with a good safety profile.
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2022.840116/full – This narrative review discusses the role of L-methylfolate in antidepressant non-responders. It provides clinical context and mechanistic rationale for its use, supporting its benefit as an adjunct in individuals with SSRI-resistant depression, aligning with meta-analytic findings.
https://consensus.app/questions/lmethylfolate-safe/ – This source provides a safety assessment of L-methylfolate based on multiple studies. It concludes that L-methylfolate at doses up to 15 mg/day is well-tolerated, with adverse events comparable to placebo, and no serious safety concerns reported in comprehensive safety reviews.